Ancora Advisors’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Ancora Advisors’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.35K	Hold	54	–	–	﹤0.01%	1617
2026 Q1	$4.68K	Hold	54	–	–	﹤0.01%	1990
2025 Q4	$4.58K	Hold	54	–	–	﹤0.01%	1980
2025 Q3	$3.92K	Buy	+54	New	+$3.73K	﹤0.01%	1542
2023 Q4	–	Sell	-111	Closed	-$6.55K	–	1793
2023 Q3	$6.55K	Hold	111	–	–	﹤0.01%	1357
2023 Q2	$6.63K	Hold	111	–	–	﹤0.01%	1340
2023 Q1	$6.49K	Hold	111	–	–	﹤0.01%	1360
2022 Q4	$7K	Hold	111	–	–	﹤0.01%	1416
2022 Q3	$6K	Hold	111	–	–	﹤0.01%	1602
2022 Q2	$7K	Buy	+111	New	+$7.05K	﹤0.01%	1688

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return

Ancora Advisors's IHE Position: Q2 2026 in Review

Ancora Advisors held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 54 shares worth $5.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1617.

Ancora Advisors first reported a position in IHE in Q2 2022 and has held it in 10 quarters since. The position peaked at $7K in Q4 2022. 209 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

Ancora Advisors held 54 shares of iShares US Pharmaceuticals ETF worth $5.35K as of Q2 2026.
Ancora Advisors left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
iShares US Pharmaceuticals ETF made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #1617 holding.
Ancora Advisors first reported a position in iShares US Pharmaceuticals ETF in Q2 2022 and has held it in 10 quarters since.
Ancora Advisors's iShares US Pharmaceuticals ETF position peaked at $7K in Q4 2022.
209 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.